Wuppertal, Germany

Frank-Thorsten Hafner

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 7.9

ph-index = 5

Forward Citations = 94(Granted Patents)


Location History:

  • Wupertal, DE (2011)
  • Wuppertal, DE (2006 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):

Title: Frank-Thorsten Hafner: Innovator in Medicinal Chemistry

Introduction

Frank-Thorsten Hafner, a distinguished inventor based in Wuppertal, Germany, has made significant contributions to the field of medicinal chemistry through his innovative research and development efforts. With a remarkable portfolio of 20 patents, Hafner focuses primarily on novel compounds aimed at enhancing cognitive functions and treating various diseases.

Latest Patents

Two of his latest groundbreaking patents include the invention of novel 2-heteroaryl carboxamides, which are aimed at producing medicaments for the treatment and/or prophylaxis of diseases, as well as for improving perception, concentration, learning, and memory. Another notable patent involves azabicyclic carbamates that serve as alpha-7 nicotinic acetylcholine receptor agonists. This innovation relates to benzothiophene-, benzofuran-, and indole ureas, offering therapeutic potential for the treatment and enhancement of cognitive functions.

Career Highlights

Throughout his career, Hafner has collaborated with reputable companies in the pharmaceutical industry, notably Bayer Intellectual Property GmbH and Boehringer Ingelheim International GmbH. These roles allowed him to hone his expertise in the development of innovative drug candidates and to significantly contribute to the advancement of medicinal compounds.

Collaborations

In addition to his professional achievements, Hafner has worked alongside notable colleagues, including Christina Erb and Franz-Josef Van Der Staay, further enriching his research environment. These collaborations have been pivotal in fostering innovation within the field and contributing to successful patent applications.

Conclusion

Frank-Thorsten Hafner represents a prime example of how dedication and innovation can lead to significant advancements in medicinal chemistry. His numerous patents reflect a commitment to improving cognitive health and treating diseases, positioning him as a key figure in the ongoing development of effective therapeutics. With continued focus on research and collaboration, Hafner's work is likely to impact the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…